Protocolo terapéutico del paciente hipertenso con patología cardíaca

  1. Rajjoub Al-Mahdi, E.A. 1
  2. Monteagudo Ruiz, J.M. 1
  3. Martínez Moya, R. 1
  4. Lorente Ros, A. 1
  5. Zamorano Gómez, J.L. 1
  1. 1 Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, España
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2021

Issue Title: Enfermedades cardiovasculares (II)

Series: 13

Issue: 36

Pages: 2113-2116

Type: Article

DOI: 10.1016/J.MED.2021.06.017 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

We present therapeutic guidelines for patients with hypertension and high cardiovascular risk. The blood pressure readings are set out from which we recommend pharmacological treatment should be started and the objectives pursued in different populations. We summarise the indications for the different available drugs and propose an algorithm for their selection according to the patients’ comorbidities.

Bibliographic References

  • Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104.
  • Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin converting enzyme inhibitors in hypertension. J Am Coll Cardiol. 2018;71(13):1474-82.
  • Zannad F, Ferreira JP, Pitt B. Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments. Eur Heart J. 2019;21SupplA:A55-60.
  • Hermida RC, Crespo JJ, Domínguez Sardiña M, Otero A, Moyá A, Ríos MT. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020;41(48):4565-4576.
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13-115.
  • Pinho Gomes AC, Rahimi K. Management of blood pressure in heart failure. Heart. 2019;105(8):589-95.
  • Page RL, O’Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM. Drugs that may cause or exacerbate heart failure. Circulation. 2016;134(6):e32-69.
  • Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström Lundqvist C. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of CardioThoracic Surgery (EACTS)The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.
  • Van Andel MM, Indrakusuma R, Jalalzadeh H, Balm R, Timmermans J, Scholte AJ. Long term clinical outcomes of losartan in patients with Marfan syndrome: follow up of the multicentre randomized controlled COMPARE trial. Eur Heart J. 2020;41(43):4181-7